NEW YORK (GenomeWeb) – Atlas Genetics announced today that it has received a two-year phase II contract from Innovate UK worth £2 million ($2.6 million), to expand its sexually transmitted infection test menu for the io rapid diagnostic platform, and to support the introduction of the platform into UK sexual health clinics.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.